How Does Salvi Rafael Folch Viadero Help Grupa Televisa?

Posted on August 06, 2017

     There are many different people who are watching Grupa Televisa, and they see the finest programming in Spanish anywhere in the world. There are ways to create better programming that Salvi Rafael Folch Viadero has tapped into, and he has created a much better network for the people who watch. There are many people who will enjoy watching these programs, and they will feel better knowing that the company works hard to save money. This article explains how the company is improving with help from Salvi, and he is allowing the company to develop a number of programs that will entertain and educate everyone.

#1: Saving Money On Programming

Salvi works quite hard to save money on programming, and he has created a number of different situations in which his programs will survive. He knows how to help the programs remain under-budget, and he believes that each program may give up a tiny amount to help fund other programs. He does this to ensure that the company is acting responsibly, and he will continue to help the programs remain on-budget while others are created.

#2: The Network Reaches Every Spanish Speaker

Grupa Televisa is the most-popular network in the Spanish-speaking world, and there are many people who will watch it every day. These are people who wish to watch in their native language, and they trust Grupa Televisa over all other companies because they know that the network has done such fine work in production.

Salvi Rafael Folch Viadero will ensure that anyone who needs help with TV production may receive it through Grupa Televisa, and he helps each program on his network save money. He has created a responsible environment where all programs are kept under-budget, produce the finest content and are released to the people of the Spanish-speaking world.

Healthcare Fund Being Launched By Highland Capital

Posted on August 01, 2017

Highland Capital has launched a healthcare fund which is worth $147m. It is being backed by South Korea National Pension Service, Shiwen Yap. Highland Capital Management has closed this private equity fund deal that is focused on healthcare. National Pension Service (NPS) of South Korea will be the anchor investor for this private equity fund. NPS was incepted in 1988. Today its value is near $499.8 billion.

 

All those who are investing in the Highland Capital fund on healthcare have specific objectives in mind with regard to their returns. These include getting opportunities for co-investment. These will be managing their strategic objectives several countries that include Korea, and China besides the US.

 

Highland Capital will be working with Stonebridge Capital in Asia. This is a Korean private equity firm. It will be co-managing this fund. It is first private equity fund from Highland Capital in Asia, which is focused on healthcare. During the past two years, Asian investors have displayed a lot of interest in this sector. But most of these investments had been done on a direct basis or through the multi-purpose funds.

 

Highland Capital is excited about this new venture as the strategy of this fund has been aligned with its core capabilities. It will be based on the deep expertise of Highland Capital in the healthcare sector. In fact, healthcare happens to be the largest industry exposure of Highland Capital. Nearly half of their private equity is related to companies that deal in healthcare.

 

This fund will be primarily targeting the healthcare companies that are based in North America as well as Asia.

 

Highland Capital has already reported over $1.5 billion in healthcare assets by 2017. It spans across several asset classes along with fund structures. In the US, the healthcare industry is facing several disruptive forces which are affecting various companies in the middle market.

 

There are demographic changes in America as the elderly population is increasing. Besides, providing higher access in Asia to various healthcare services leads to much greater levels of utilization. This will lead to highly complex consumer demands as well as government demands too, on this sector.

Follow Highland Capital Management on Twitter for more information.

The Cosmetic Surgeon, Dr. Jennifer Walden

Posted on July 30, 2017

Dr. Jennifer Walden refers to an American female plastic surgeon with the certification from the American Plastic Surgery Panel as well as fellowship-trained in cosmetic surgery. The specialization of Dr. Walden is in facial surgery and appealing breast. It is worth noting that she executes some breast amplification, lift, and facial processes such as rhinoplasty.

Notably, she has made a presentations both nationally and globally concerning certain topics about her expertise. In the course of her exercise, whatever it takes is done to ensure that the patients make their choices when they are very informed regarding what they need. This is a way of securing the attainment of the outcome that is as natural as possible. They intend to make one have their finest desired feeling about themselves. It is for this reason that they are devoted to the best level of patient safety, care as well as contentment in a surrounding that is not intimidating and Jennifer on Facebook.

Looking at her earlier life, she was born and raised in Texas, particularly Austin. It can be said that she was born to a medical family in the view her father is a dentist and the mother is a surgical nurse. She attended Anderson High School before joining University. She attained her Bachelor’s degree from the University of Texas in the field of Biology. It is upon the successful completion of her Bachelor’s degree that Walden made her application to the Medical School at the Medical Branch of the University of Texas. Despite the University’s waitlisting, she came out to be a salutatorian while graduating from her class and learn more about Jennifer.

Dr. Jennifer Walden is famous to many for her utilization and establishment of progressive technologies in the course of carrying out her duties. The quality services and the satisfaction that the clients get is the reason behind her prosperity and read full article.

Other Reference: http://www.vitals.com/doctors/Dr_Jennifer_Walden/reviews

Mikhail Blagosklonny devotion to Acquiring an Effective Cancer Treatment

Posted on July 28, 2017

Mikhail Blagosklonny is an oncology professor at the Roswell Park Cancer Institution. He is a scientist and specializes in cancer and aging. He has an M.D. in internal medicine from the First Pavlov State Medical University, St. Petersburg. He advanced his education in the same university and attained a PhD in experimental medicine and cardiology.In 2002, Mikhail was appointed as the associate professor of medicine at the New York Medical College situated in Valhalla, New York. He was hired by the Ordway Research Institute in Albany, New York, as a senior scientist. In 2009, Mikhail became a professor of oncology at the renowned Roswell Park Cancer Institute. He had gained vast knowledge and experience in his previous workplaces, and this made him an excellent professor. Mikhail based his research on biogerontology (the underlying mechanism of aging), cancer, anti-aging drugs, as well as cancer therapies which guard the healthy body cells against destruction.

Mikhail also serves as the editor-in-chief of Oncotarget, and Aging. He is not only the founder editor of Cell Cycle but also the editor-in-chief. He is an associate editor of cancer therapy and biology. Mikhail is on the editorial panel of Cell Death and Differentiation. He released a proposition concerning the potential role of TOR signalling in cancer and aging. In the hypothesis, Mikhail proposed the utilization of Rapamycin as a possible treatment for life extension.Mikhail gives insight into how rejuvenation of cells helps to reduce the incidences of cancer in aged people. Mikhail defines aging as the progressive growth of cells. Rapamycin is a drug used to treat cancer. Mikhail is one of the enthusiastic advocates for Rapamycin in the longevity research. Mikhail argues that the usage of Rapamycin can minimize the aging process in human beings as it strengthens the body’s immunity. Over the years, scientists have provided several results on the use of anti-aging products in cancer management.

Most of Mikhail studies range from clinical investigations to molecular and cellular biology. The studies include ontogenesis, apoptosis, anti-cancer therapeutics, signal transduction, tumor suppressors, cell cycle, mitosis, and drug resistance for normal body cells. Mikhail writes about aging hyperfunction theory, chemotherapeutic, and cyclotherapy engineering. He has published more than 300 book chapters, research articles and reviews. Mikhail Blagosklonny has used approximately 25,000 citations, therefore, has an h-index of 83. Also, he is an associate editor of the American Journal of Pathology, PLOS ONE, and the International Journal of Cancer.Mikhail Blagosklonny is famous for his passion in oncology. He firmly believes that controlling aging and cancer is achievable. According to Mikhail, cancer can be cured, which is why he recommends the use of Rapamycin. Mikhail’s devotion to his work has brought great achievements in his field of specialization. He is one of the greatest oncologist researchers in the world today. His achievements are attributed to his love for humanity and his vision for a disease free society.It is clear that Mikhail is an accomplished Scientist, professor of oncology and medicine, and physician. He has risen through ranks and holds several top-notch appointments.

Agora Financial Your Investment Partner

Posted on July 26, 2017

New investors are afraid to invest their money in ventures that they know very little about as well as investments controlled by brokerage firms. Agora Financial is a publishing company that absorbs all the investor’s risk by providing the investors with viable information that will enable them to invest wisely. The company carries out research on behalf of the investors, and provides them with a detailed analysis of the ventures to undertake.

The success of the company is accredited to the experienced workforce working in the firm. The company’s personnel have diversified skills such as journalism, film making, geology, writing, and management in banks and hedge-funds. These skills are essential in obtaining viable research details. The company can finance trips abroad for their employees; this awards them a chance to find new ventures in both developed and developing countries.

Agora Financial communicates to its clients via publications, emails, and conferences. The company can send its customers emails informing them of their new ventures. The firm organizes conferences to educate its customers on the areas to invest, ways to manage their wealth, and ways to protect their current investments.

Agora Financial Profile

Agora Financial is a publishing entity that was established in 1979 by Bill Bonner. The company headquarters are based in Baltimore, Maryland. Before founding the company, Bill was a financial writer and an essayist. He is renowned for writing Empire of Debt and Financial Reckoning Day.

The company has made several publications such as Breakthrough Technology Alert; this piece advises potential investors on the investment opportunities available in the technology sector. The company is renowned for making several predictions the business world. For instance, the firm predicted the failure of mortgage bonds in 2004 and the rise in the price of oil. The first prediction was accurate as the mortgage market collapsed in 2007 costing investors their money.

For more information on Agroa Financial on Facebook.

Benefits of Ubuntu Fund by Andrew Rolfe

Posted on July 25, 2017

Andrew Rolfe is the Chairman of the Ubuntu Education Fund. Andrew Rolfe has shown his interests in the educational sector for a long time. His interest in education started during his childhood. Andrew attended the University of Oxford. At the university, Rolfe earned a degree in Bachelor of Arts in Philosophy, Politics, and Economics. After that, Rolfe saw the need for advancing his education. Andrew Rolfe attended the Harvard Business School for his masters in Business Administration.

Later, Andrew Rolfe was satisfied with his achievements in education. Andrew decided to utilize the knowledge he acquired to be a productive member of the society. Andrew thus became the President of The Gap’s International Division. Andrew Rolfe became responsible for the company’s operations in four major countries namely France, Germany, Japan and United Kingdom. The company also put Rolfe in charge of its set strategies to attain international growth.

Being the Ubuntu’s Fund Chairman, Rolfe welcomed the 300 attendees to the music gala performed by a Xhosa choir. Among the attendees were two student beneficiaries of the Ubuntu Fund. During the event, Ubuntu Fund hoped to raise $972,960. The money was meant to benefit the Ubuntu Fund’s school campus located in Port Elizabeth. Also, the raised fund is aimed to create opportunities for the less fortunate children in the local area. The funds will enable underprivileged children to attend schools like others. The children will be given full support until they eventually start their careers.

Andrew Rolfe is also the President of International Division. His activities in the company are reported to the CEO and President of Gap Inc., Paul Pressler. Mr. Rolfe was also appointed to be among the members of the Executive Leadership Team of the company. With time, Andrew has managed to retain the company’s brands globally by providing high customer satisfaction. In 1987, Gap Inc. opened its first store outside the US in London. As of 2003, Gap Inc. runs operations in 261 stores in UK, Germany, France, and Japan.

Before joining Gap Inc., Andrew Rolfe worked at Pret A Manger. Mr. Rolfe was the company’s Chairman. Pret A Manger is based in London. The company dealt with food retailing with operations in Tokyo, UK, Hong Kong and New York. Rolfe’s success is attributed to his global experience.

 

Mikhail Blagosklonny’s Contributions to Oncology and Anti-Aging

Posted on July 23, 2017

After extensive research, Mikhail Blagosklonny is convinced that aging can be prevented. With proper treatment, people can live longer. He proposed the use of rapalogs like rapamycin to prevent aging as well as the diseases that result from aging. Everolimus (RAD001) can be used to boost immunity. This research is helpful to the youth as well as the old people. It will help people to live long and healthy lives and aging will not be dreaded anymore. According to Nir Barzilai, the success and use of the “fountain of youth drug” will be a milestone in research.

Rapamune could be used to treat age-related diseases like Alzheimer’s and osteoporosis. The drug was already available in the market for use in the treatment of autoimmune diseases, cancer, and cardiovascular diseases. Rapamycin could work better as a preventive rather than a curative drug for aging and age-related diseases. The drug has been in use to help patients who are undergoing transplants. It reduces the chances of the patient’s body rejecting foreign organs. This makes the drug suitable for everyday use even for slowing down the aging process. Read more about Mikhail at LinkedIn

According to the research by Mikhail Blagosklonny, the treatment would make an adult have the immunity of a child. The treatments will reduce the number of people who die because of age. Damaged molecules and selfish mitochondria among several other factors cause aging.

Mikhail Blagosklonny has also done a lot of research in oncology. Some of the things that he has researched on include anticancer therapeutics, tumor suppressors, mitosis, therapies that prevent healthy cells from being affected by cancer and apoptosis. Through his research, he realized that cancer can be cured. Rapamycin, which was proposed to treat aging, could also cure cancer. His commitment to discovering solutions to problems in oncology and aging has made him an expert in the fields.

Mikhail Blagosklonny attended the First Pavlov State Medical University of St. Petersburg. There he got his MD in Internal Medicine and his Ph.D. in Experimental Medicine and Cardiology. He has been at Roswell Park Cancer Institute as an oncology professor since 2009. Before then, he worked at the New York Medical College as an associate professor. He was also a senior scientist at the Ordway Research Institute. His research and experience make Mikhail an excellent professor.

Mikhail Blagosklonny also writes a lot about aging and oncology. He shares his finding with other people who have similar interests. Cell Cycle and Oncotarget have him as the editor-in-chief. In Cancer Biology and Therapy, he serves as an associate editor. Mikhail sits on the editorial board of Cell Death and Differentiation. He is regarded as one of the people who strongly believe in the use of Rapamycin. Visit ResearchGate to know more about Mikhail’s latest work.

The hyperactive function theory, chemotherapeutic engineering, and cyclotherapy are some of the subjects that Mikhail has written extensively about them. He has more than 300 publications including books, reviews, and research articles. According to Mikhail Blagosklonny, his motivation comes from his dream to eradicate diseases.

How Eric Lefkofsky’s Colossal Genomic Database Will Benefit Cancer Patients

Posted on July 23, 2017

While Eric Lefkofsky graduated from the University of Michigan with a law degree, his real talent is being an entrepreneur who thrives on risk. In fact, Lefkofsky’s latest venture is genomics company, even though he has no medical background.

As the co-founder and CEO at Tempus, Lefkofsky oversees the compilation of a colossal database that physicians can use to personalize cancer therapies. Actually, Tempus is based on utilizing big data, as were Lefkofsky’s previous ventures, therefore it isn’t so unusual that he would compile gene-sequencing test results. With numerous Ph.D.s working at Tempus, Lefkofsky’s role is to bring the data together and make it simple for physicians to utilize. Tempus does this by partnering with hospitals that contribute data in return for software, which doctors will use to compare their cancer patient’s genetic profile to other profiles already in the database, in order to determine which treatments have been successful in similar cases.

In addition to co-founding Tempus, Lefkofsky also co-founded Lightbank, a venture fund that invests in diverse companies, especially startups employing disruptive technologies. Lefkofsky wrote a book titled Accelerated Disruption: Understanding the True Speed of Innovation, where he explains why businesses utilizing disruptive tactics often succeed where others fail. In his book, Lefkofsky warns potential entrepreneurs not to hesitate, because with technology, a competitor could easily overtake them and get their idea to market first.

A Chicago resident, Lefkofsky is active in his community; he sits on the boards of the Art Institute of Chicago, the Children’s Memorial Hospital and The Museum of Science and Industry. Adjunct Professor Eric Lefkofsky also teaches course on entrepreneurship at the University of Chicago Booth School of Business.

If anyone knows about entrepreneurship, it is Lefkofsky, who co-founded InnerWorkings, Echo Global Logistics, MediaBank and ThePoint.com. In his spare time, Lefkofsky oversees the Lefkofsky Foundation, which supports charitable causes around the world.

About Eric Lefkofsky: www.tempus.com/about-us/

Troy McQuagge: Chief executive of the year 2016

Posted on July 22, 2017

Troy McQuagge is from Panama City, Florida and is a well-known entrepreneur. He completed his education from the University of Central Florida and currently lives in Coppell, Texas where he is the Corporate Executive for USHEALTH, Inc. He has a vast experience in sales and marketing strategies. McQuagge started his career as a health insurance sales agent. In the year 1983 he worked for Allstate insurance and worked over there for almost a decade. In 1995, Troy McQuagge decided to go to UICI/Health Market.

 

 

Troy McQuagge has been awarded the prestigious title of ‘Chief Executive Officer of the year’ in award ceremony ‘one planet”. In One Planet awards, the most professional and hard-working recognized personalities are awarded gold titles, One Planet awards are premier awards and institutes from each country are allowed to submit nominations whether they belong to a private organization or a public institute. Even small businesses and new start-ups can be nominated in different categories.

 

 

CEO Mr. McQuagge commissioned in USHEALTH in early 2010, and without any delay he brought reforms. His main idea was to re-establish the institutes captive distribution agency which meant to re-position the advisory committee. This idea of Mr. McQuagge to power up the advisors was a success and paved the way for him to be an elected representer and Chief Executive of USHEALTH organization, Inc. During his time in 2014, he led USHEALTH to enormous and unprecedented success. The Profit charts and growth rate of the company were no match for others in the supremely competitive health insurance market.

 

 

During the award ceremony, Mr. McQuagge expressed his feelings “it’s an honor to be named by One Planet Awards, but I am not the only person who deserves this prestigious title, everyone in the USHEALTH is behind this effort, and this belongs to them. It’s our priority to solve affordability issues regarding health care and provide our customers the best possible and innovative health coverage according to their health needs.”

 

 

About the One Planet Awards

 

 

Companies with a high professionalism rate and excellent business strategies are recognized by One Planet awards for best and excellent professionalism throughout the year.

 

 

Website Link: http://www.oneplanetawards.com/

 

 

Information about USHEALTH Group, Inc

 

 

This organization is mainly an insurance company located in FT. worth, Texas. USHEALTH is keen to provide best health coverage to their customers. The main aim of this institute is to market insurance products by the help of its talented agents and employees.

Productive Philanthropy Work of Betsy DeVos

Posted on July 20, 2017

Betsy DeVos was known to be the U.S secretary of education. She played a significant role in the sphere of education after being confirmed by Senate after being nominated by the U.S president Donald Trump.She has advocated for many policies on matters concerning children in the field of education for decades. Furthermore, she acted as the voice for the parents on issues that entail reforms in the sector of education. Through this, she has helped many underserved children acquire access to the education that meets the required standards. Her interest in the matter of education was traced way back at her early age when she was confronted that not all children are granted equal opportunity to education.Throughout her life, she played a significant role as a reformer she gets involved in the campus politics and remained active in the field of politics. She acted as the chief campaigner and led a lot of campaigns and party organizations.

Though his program, she became optimistic in the sense that the turnout of enrollment of students in public funded was increasing gradually. The fruits of the movement were accelerating at a higher pace, and the educational –choice program grew by almost 40,000.Their agenda saw the integration of the new programs in Pennsylvania, Florida and Virginia expanded to the other parts of the U.S. The ideas of Betsy DeVos placed the matters of education at a vantage position of achieving its goals.When Betsy DeVos and Dick visited one of the schools, Potter’s House Christian School, which was serving the low-income families, they met the parents who were sacrificing their lives to take their children to schools that were safer. This motivated the two to create a better platform that will establish equality for all in the arena of education. The two had enough resources to boost the level of their education, and they started supporting some of the students at a significant level.

They committed their time and dedicated they mind in creating a smoother manner of running the program by involving the key players.Their project has also led to the significant advancement of programs of education in some part such as Louisiana and Indiana. The two states have expanded the potential serve to reach almost one million students within a year. This has bestowed a lot of trust to the program by the least income families with the widespread adoption of the educational choice. The better part of the idea in the incorporation of the skilled experts in the crafting of the programs.As a matter of fact, Betsy DeVos played a substantial role in creating a platform that integrated the less fortunate families in the sphere of education.

Learn more about her : http://www.philanthropyroundtable.org/topic/excellence_in_philanthropy/interview_with_betsy_devos